<DOC>
	<DOCNO>NCT00471029</DOCNO>
	<brief_summary>The purpose study compare gastric acid suppression profile among different regimen ( Oral Vs Intravenous ) administration proton pump inhibitor - Esomeprazole 24hours intragastric pH monitoring .</brief_summary>
	<brief_title>Compare Efficacy Gastric Acid Suppression Oral Intravenous Administration Esomeprazole Patients With Peptic Ulcer</brief_title>
	<detailed_description>Peptic ulcer bleed common medical emergency . Although primary hemostasis achieve endoscopic hemostasis 90 % case , rebleeding first 72 hour still common . The use secretory inhibitor ulcer bleed theoretical benefit prevent rebleeding . In vitro , platelet aggregation disaggregation , coagulation fibrinolysis strongly dependent intra-gastric pH . When pH fall 6.0 , platelet disaggregation take place 4.0 , fibrin clot dissolve . Pharmacological study clearly show primed proton-pump inhibitor ( PPI ) infusion superior H2-receptor blocler ( H2B ) injection infusion maintain high intra-gastric pH . Randomized trial demonstrate advantage adjuvant use intravenous oral PPI reduce rebleeding compare placebo . However , Asian subject generally low body weight acid output Caucasians , dosage PPI required prevent rebleeding may different . Lin et al demonstrated Asian population study , order show significant clinical effect prevent peptic ulcer rebleeding endoscopic hemostasis , least 30 % difference duration maintain intragastric pH &gt; 6 must achieve . As substantial cost implication routine use high dose intravenous PPI infusion ( 80mg bolus + 8mg/hour 72 hour , cost ~HKD $ 1100 ) high dose oral esomeprazole ( 40mg BD 3 day , cost ~HKD $ 60 ) , optimal dos rout administration PPI achieve effective acid suppression need clearly define . Protocol : Patients present bleed peptic ulcer ( melena , hememtesis ) undergo endoscopy . If clean base peptic ulcer do require endoscopic treatment diagnose , consent patient randomly allocate 2 group use sealed envelope contain therapeutic option derive randomize table . 1 . Esomeprazole infusion ( 80mg bolus 8mg/hour ) ( 192mg/d ) 2 . Esomeprazole Tablet oral 40mg 12 hourly ( 80mg/d ) A pH electrode internal reference ( Synetic ) insert transnasally position 10cm cardia . It calibrate pH record standard buffer solution pH 7.00 pH 1.00 . The electrode connect data logger ( Mircodigitrapper , Synetic ) . At end 24hours recording , data transfer personal computer analysis . Medication give insertion intra-gastric pH monitor probe . Outcome measure Primary Outcome : total % Time pH &gt; 6 &amp; 4 Secondary outcome : Median intragastric pH &amp; Time reach pH 4 6</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Peptic Ulcer</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<criteria>1 . Patients nonbleeding peptic ulcer require endoscopic therapy . 2 . Chinese , Age ³18 &lt; 90 3 . Provision inform write consent sign patient . 1 . Treatment antisecretory drug precede 4 week 2 . The present intercurrent ulcer complication ( gastric outlet obstruction ulcer perforation ) 3 . Presence esophageal / gastric varix 4. aspirin NSAID user 5 . Pregnancy 6 . Age &lt; 18 &gt; 90 7 . Moribund patient , patient severe liver renal disease 8 . Known sensitivity proton pump inhibitor 9 . Previous gastric surgery ( except simple patch repair ) 10 . Patient unable give write consent 11 . Special population , e.g . prisoner , mentally disabled , investigator ’ student employee</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>May 2007</verification_date>
	<keyword>pH study , peptic ulcer , proton pump inhibitor</keyword>
</DOC>